263 related articles for article (PubMed ID: 8957248)
1. 8-OH-DPAT-induced release of hippocampal noradrenaline in vivo: evidence for a role of both 5-HT1A and dopamine D1 receptors.
Hajós-Korcsok E; Sharp T
Eur J Pharmacol; 1996 Oct; 314(3):285-91. PubMed ID: 8957248
[TBL] [Abstract][Full Text] [Related]
2. Two selective 5-HT1A receptor antagonists, WAY-100 635 and NDL-249, stimulate locomotion in rats acclimatised to their environment and alter their behaviour: a behavioural analysis.
Jackson DM; Wallsten CE; Jerning E; Hu PS; Deveney AM
Psychopharmacology (Berl); 1998 Oct; 139(4):300-10. PubMed ID: 9809851
[TBL] [Abstract][Full Text] [Related]
3. Effects of WAY 100635 and (-)-5-Me-8-OH-DPAT, a novel 5-HT1A receptor antagonist, on 8-OH-DPAT responses.
Trillat AC; Malagié I; Mathé-Allainmat M; Anmela MC; Jacquot C; Langlois M; Gardier AM
Eur J Pharmacol; 1998 Apr; 347(1):41-9. PubMed ID: 9650846
[TBL] [Abstract][Full Text] [Related]
4. Similar pharmacological properties of 8-OH-DPAT and alnespirone (S 20499) at dopamine receptors: comparison with buspirone.
Protais P; Lesourd M; Comoy E
Eur J Pharmacol; 1998 Jul; 352(2-3):179-87. PubMed ID: 9716353
[TBL] [Abstract][Full Text] [Related]
5. (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists.
Schreiber R; Brocco M; Audinot V; Gobert A; Veiga S; Millan MJ
J Pharmacol Exp Ther; 1995 Apr; 273(1):101-12. PubMed ID: 7714755
[TBL] [Abstract][Full Text] [Related]
6. Neurochemical evaluation of the novel 5-HT1A receptor partial agonist/serotonin reuptake inhibitor, vilazodone.
Hughes ZA; Starr KR; Langmead CJ; Hill M; Bartoszyk GD; Hagan JJ; Middlemiss DN; Dawson LA
Eur J Pharmacol; 2005 Mar; 510(1-2):49-57. PubMed ID: 15740724
[TBL] [Abstract][Full Text] [Related]
7. A critical role for D1 receptors in the 5-HT1A-mediated facilitation of in vivo acetylcholine release in rat frontal cortex.
Consolo S; Ramponi S; Ladinsky H; Baldi G
Brain Res; 1996 Jan; 707(2):320-3. PubMed ID: 8919313
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous quantification of serotonin, dopamine and noradrenaline levels in single frontal cortex dialysates of freely-moving rats reveals a complex pattern of reciprocal auto- and heteroreceptor-mediated control of release.
Gobert A; Rivet JM; Audinot V; Newman-Tancredi A; Cistarelli L; Millan MJ
Neuroscience; 1998 May; 84(2):413-29. PubMed ID: 9539213
[TBL] [Abstract][Full Text] [Related]
9. Effect of WAY-100135 on the hippocampal acetylcholine release potentiated by 8-OH-DPAT, a serotonin1A receptor agonist, in normal and p-chlorophenylalanine-treated rats as measured by in vivo microdialysis.
Nakai K; Fujii T; Fujimoto K; Suzuki T; Kawashima K
Neurosci Res; 1998 May; 31(1):23-9. PubMed ID: 9704975
[TBL] [Abstract][Full Text] [Related]
10. Estimation of apparent pA2 values for WAY 100635 at 5-HT1A receptors regulating 5-hydroxytryptamine release in anaesthetised rats.
Assié MB; Koek W
Eur J Pharmacol; 2000 Dec; 409(2):173-7. PubMed ID: 11104831
[TBL] [Abstract][Full Text] [Related]
11. Estrogen treatment blocks 8-hydroxy-2-dipropylaminotetralin- and apomorphine-induced disruptions of prepulse inhibition: involvement of dopamine D1 or D2 or serotonin 5-HT1A, 5-HT2A, or 5-HT7 receptors.
Gogos A; Kwek P; Chavez C; van den Buuse M
J Pharmacol Exp Ther; 2010 Apr; 333(1):218-27. PubMed ID: 20042529
[TBL] [Abstract][Full Text] [Related]
12. WAY-100635 inhibits 8-OH-DPAT-stimulated oxytocin, ACTH and corticosterone, but not prolactin secretion.
Vicentic A; Li Q; Battaglia G; Van de Kar LD
Eur J Pharmacol; 1998 Apr; 346(2-3):261-6. PubMed ID: 9652368
[TBL] [Abstract][Full Text] [Related]
13. Neurochemical profile of the selective and silent 5-HT1A receptor antagonist WAY100135: an in vivo microdialysis study.
Routledge C; Gurling J; Wright IK; Dourish CT
Eur J Pharmacol; 1993 Aug; 239(1-3):195-202. PubMed ID: 8223894
[TBL] [Abstract][Full Text] [Related]
14. The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes.
Gozlan H; Thibault S; Laporte AM; Lima L; Hamon M
Eur J Pharmacol; 1995 Jan; 288(2):173-86. PubMed ID: 7720779
[TBL] [Abstract][Full Text] [Related]
15. Dopamine receptor antagonist properties of S 14506, 8-OH-DPAT, raclopride and clozapine in rodents.
Protais P; Chagraoui A; Arbaoui J; Mocaër E
Eur J Pharmacol; 1994 Dec; 271(1):167-77. PubMed ID: 7698199
[TBL] [Abstract][Full Text] [Related]
16. In the formalin model of tonic nociceptive pain, 8-OH-DPAT produces 5-HT1A receptor-mediated, behaviorally specific analgesia.
Bardin L; Tarayre JP; Koek W; Colpaert FC
Eur J Pharmacol; 2001 Jun; 421(2):109-14. PubMed ID: 11399266
[TBL] [Abstract][Full Text] [Related]
17. 5-hydroxytryptamine (5-HT)1A receptors and the tail-flick response. I. 8-hydroxy-2-(di-n-propylamino) tetralin HBr-induced spontaneous tail-flicks in the rat as an in vivo model of 5-HT1A receptor-mediated activity.
Millan MJ; Bervoets K; Colpaert FC
J Pharmacol Exp Ther; 1991 Mar; 256(3):973-82. PubMed ID: 1826033
[TBL] [Abstract][Full Text] [Related]
18. Labelling of recombinant human and native rat serotonin 5-HT1A receptors by a novel, selective radioligand, [3H]-S 15535: definition of its binding profile using agonists, antagonists and inverse agonists.
Newman-Tancredi A; Verrièle L; Chaput C; Millan MJ
Naunyn Schmiedebergs Arch Pharmacol; 1998 Mar; 357(3):205-17. PubMed ID: 9550290
[TBL] [Abstract][Full Text] [Related]
19. A drug discrimination analysis of the actions of novel serotonin1A receptor ligands in the rat using the 5-HT1A receptor agonist, 8-hydroxy-2-(di-n-propylamino)tetralin.
Schreiber R; Brocco M; Lefèbvre de Ladonchamps B; Monneyron S; Millan MJ
J Pharmacol Exp Ther; 1995 Nov; 275(2):822-31. PubMed ID: 7473172
[TBL] [Abstract][Full Text] [Related]
20. A pharmacological profile of the selective silent 5-HT1A receptor antagonist, WAY-100635.
Forster EA; Cliffe IA; Bill DJ; Dover GM; Jones D; Reilly Y; Fletcher A
Eur J Pharmacol; 1995 Jul; 281(1):81-8. PubMed ID: 8566121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]